Skip to main content
SpringerLink
Log in

Clinical Scenario: T2 Bladder Tumor

48-year-old healthy man with 4 cm, T2 urothelial carcinoma and negative metastatic evaluation who desires immediate cystectomy without neoadjuvant chemotherapy, erectile function preservation, and an ileal neobladder

  • Chapter
  • First Online:
Management of Bladder Cancer

Abstract

The clinical scenario of a 48-year-old healthy man with 4 cm, T2 urothelial carcinoma and negative metastatic evaluation who desires immediate cystectomy without neoadjuvant chemotherapy, erectile function preservation, and an ileal neobladder is presented.

We recommend that cisplatinum-based neoadjuvant chemotherapy (NACT) be restricted to patients with undebated non-organ-confined urothelial BC (cT3, cT4a) and/or lymph node-positive disease (cNI). The chances of cure and of understaging are discussed with surgery, and capsule, prostate and seminal vesicle-sparing radical cystectomy (RC) is discussed as well as the high complication rates within 90 days of surgery (58 %) and long term (40 %). Postoperative care is outlined as well as differences in the robotic versus open approach and with a female patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goossens-Laan CA, Visser O, Hulshof MC, Wouters MW, Bosch JL, Coebergh JW, Kil PJ. Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume. BJUI. 2011;110:226–32.

    Article  Google Scholar 

  2. International Bladder Cancer Nomogram Consortium. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006;24:3967–72.

    Article  Google Scholar 

  3. Mitra AP, Skinner EC, Miranda G, Daneshmand S. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. BJU Int. 2012;111:240–8.

    Article  PubMed  Google Scholar 

  4. Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JJ. A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aNO-N2MO bladder cancer. Cancer. 2012;118:358–64.

    Article  CAS  PubMed  Google Scholar 

  5. Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF, Crawford ED. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004;22:2781–9.

    Article  PubMed  Google Scholar 

  6. Herr HW, Dotan Z, Donat SM, Bajorin DF. Defining optimal therapy for muscle invasive bladder cancer. J Urol. 2007;177:437–43.

    Article  CAS  PubMed  Google Scholar 

  7. Hautmann RE, Stein JP. Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: a step in the wrong direction. Urol Clin N Am. 2005;32:177–85.

    Article  Google Scholar 

  8. Kiefer JC, Cherullo EE, Jones JS, Gong MC, Campbell SC. Prostate-sparing cystectomy: has Pandora’s box been opened? Expert Rev Anticancer Ther. 2007;7(7):1003–14.

    Article  Google Scholar 

  9. Hautmann RE, Hautmann O, Volkmer BG, Hautmann S. Nerve-sparing radical cystectomy: a new technique. Eur Urol Suppl. 2010;9:428–32.

    Article  Google Scholar 

  10. Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol. 2010;184:990–4.

    Article  PubMed  Google Scholar 

  11. Hautmann RE, de Petriconi RC, Volkmer BG. 25 Years of experience with 1,000 neobladders: long-term complications. J Urol. 2011;185:2207–12.

    Article  PubMed  Google Scholar 

  12. Hautmann RE, Botto H, Studer UE. How to obtain good results with orthotopic bladder substitution: the 10 commandments. Eur Urol Suppl. 2009;8:712–7.

    Article  Google Scholar 

  13. Hautmann RE, Abol-Enein H, Davidsson T, Gudjonsson S, Hautmann SH, Holm HV, Lee CT, Liedberg F, Madersbacher S, Manoharan M, Mansson W, Mills RD, Penson DF, Skinner EC, Stein R, Studer UE, Thueroff JW, Turner WH, Volkmer BG, Abai X. ICUD-EAU international consultation on bladder cancer 2012: urinary diversion. Eur Urol. 2013;63:67–80.

    Article  PubMed  Google Scholar 

  14. Hautmann RE. The oncologic results of laparoscopic radical cystectomy are not (yet) equivalent to open cystectomy. Curr Opin Urol. 2009;19:522–6.

    Article  PubMed  Google Scholar 

  15. Laudone V. Late breaking news: interim analysis of a prospective randomized trial comparing robotic and open cystectomy at memorial sloan-kettering cancer center. J Urol. 2013: 116.

    Google Scholar 

  16. Hautmann RE. The Ileal Neobladder. Atlas Urol Clin North Am. 2001;9(2):85.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Ulm, Boschstrasse 4a, 89231, Neu-Ulm, Germany

    Richard E. Hautmann M.D., M.D. hon

Authors
  1. Richard E. Hautmann M.D., M.D. hon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard E. Hautmann M.D., M.D. hon .

Editor information

Editors and Affiliations

  1. Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA

    Badrinath R. Konety

  2. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    Sam S. Chang

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hautmann, R.E. (2015). Clinical Scenario: T2 Bladder Tumor. In: Konety, B., Chang, S. (eds) Management of Bladder Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1881-2_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1881-2_26

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1880-5

  • Online ISBN: 978-1-4939-1881-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation